Recognition and management of complications during transcatheter aortic valve implantation

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 7, 2011, Pages 913-926

  Shannon, Joanne ^a,c   Mussardo, Marco ^b   Latib, Azeem ^a   Takagi, Kensuke ^a   Chieffo, Alaide ^b   Montorfano, Matteo ^b   Colombo, Antonio ^a  

^a EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

annulus rupture; aortic stenosis; atrioventricular block; cerebral embolism; complications; coronary occlusion; embolization; paravalvular regurgitation; tamponade; transcatheter aortic valve implantation; vascular access

Indexed keywords

AORTA DISSECTION; ARTERY PERFORATION; ARTICLE; BLOOD VESSEL INJURY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART TAMPONADE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PROGNOSIS; PROSTHESIS LOOSENING; SURGICAL APPROACH; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBOSIS; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AORTIC VALVE; AORTIC VALVE STENOSIS; EQUIPMENT DESIGN; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK;

EID: 79961193711     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.84     Document Type: Article

References (52)

1. Grube E, Schuler G, Buellesfeld L et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol. 50, 69-76 (2007). (Pubitemid 46970878)
2. Webb JG, Pasupati S, Humphries K et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116(7), 755-763 (2007). (Pubitemid 47255993)
3. Thomas M, Schymik G, Walther T et al. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122, 62-69 (2010).
4. Piazza N, Grube E, Gerckens U et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 4(2), 242-249 (2008).
5. Zahn R, Gerckens U, Grube E et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 32(2), 198-204 (2011).
6. Eltchaninoff H, Prat A, Gilard M et al. Transcatheter aortic valve implantation: early results of the FRANCE (French Aortic National CoreValve and Edwards) registry. Eur. Heart J. 32(2), 191-197 (2011).
7. Tamburino C, Capodanno D, Ramondo A et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123, 299-308 (2011).
8. Bosmans JM, Kefer J, De Bruyne B et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact. Cardiovasc. Thorac. Surg. 12, 762-767 (2011).
9. Khawaja MZ, Rajani R, Cook A et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative).Circulation 123(9), 951-960 (2011).
10. Leon MB, Smith CR, Mack M et al.; for the PARTNER trial investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363, 1597-1607 (2010).
11. Buellesfeld L, Gerckens U, Schuler G et al. 2-Year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J. Am. Coll. Cardiol. 57, 1650-1657 (2011).
12. Lichtenstein SV, Cheung A, Ye J et al. Transapical transcatheter atic valve implantation in humans: initial clinical experience. Circulation 114(6), 591-596 (2006). (Pubitemid 44202060)
13. Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113(6), 842-850 (2006).
14. Grube E, Laborde JC, Gerckens U et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114(15), 1616-1624 (2006). (Pubitemid 44547432)
15. Bagur R, Rodés-Cabau J, Doyle D. Usefulness of TEE as the primary imaging technique to guide transcatheter transapical aortic valve implantation. JACC Cardiovasc. Imaging 4(2), 115-124 (2011).
16. Van Mieghem NM, Nuis R, Piazza N et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System®: the Rotterdam experience. EuroIntervention 5, 673-679 (2010).
17. Kahlert P, Al-Rashid F, Weber M et al. Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz 34, 398-408 (2009).
18. Ducrocq D, Francis F, Serfaty JM et al. Vascular complications o transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention 5, 666-672 (2010).
19. Tchetche D, Dumonteil N, Sauget A et al. 30 day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprosthesis in a mixed population. EuroIntervention 5, 659-665 (2010).
20. Webb JG, Altwegg L, Boone RH et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 119, 3009-3016 (2009).
21. Leon MB, Piazza N, Nikolsky E et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J. Am. Coll. Cardiol. 57(3), 253-269 (2011).
22. Eggebrecht H, Kahlert P, Thielmann M, Plicht B, Erbel R. Usefulness of a novel balloon-expandable vascular sheath for facilitated large-bore arterial access for transcatheter aortic valve implantation. EuroIntervention 6, 893-894 (2011).
23. Sharp ASP, Michev I, Maisano F et al. A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc. Interv. 75, 784-793 (2010).
24. Masson J, Kovac J, Schuler G et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. J. Am. Coll. Cardiol. 2, 811-820 (2009).
25. Al Ali AM, Altwegg L, Horlick EM et al. Prevention and management of transcatheter balloon-expandable aortic valve malposition. Catheter Cardiovasc. Interv. 72, 573-578 (2008).
26. Geisbüsch S, Bleiziffer S, Mazzitelli D et al. Incidence and management of corevalve dislocation during transcatheter aortic valve implantation. Circ. Cardiovasc. Interv. 3, 531-536 (2010).
27. Tops LF, Krishnan SC, Schuijf JD, Schalij MJ, Bax JJ. Noncoronary applications of cardiac multi-detector row computed tomography. JACC Cardiovasc. Imaging 1, 94-106 (2008). (Pubitemid 351447180)
28. Rivard AL, Bartel T, Bianco RW et al. Evaluation of aortic root and valve calcifications by multi-detector computed tomography. J. Heart Valve Dis. 18, 662-670 (2009).
29. Geist V, Sherif MA, Khattib AA. Successful percutaneous coronary intervention after implantation of a CoreValve percutaneous aortic valve. Catheter Cardiovasc. Interv. 73, 61-67 (2009).
30. Stabile E, Sorropago G, Cioppa A et al. Acute left main obstructions following TAVI. EuroIntervention 6, 100-105 (2010).
31. Gogas BD, Zacharoulis AA, Antoniadis AG. Acute coronary occlusion following TAVI. Catheter Cardiovasc. Interv. 77(3), 435-438 (2011).
32. Webb JG. Coronary obstruction due to transcatheter valve implantation Catheter Cardiovasc. Interv. 73, 973 (2009).
33. Wong DR, Boone RH, Thompson CR et al. Mitral valve injury late after transcatheter aortic valve implantation. J. Thorac. Cardiovasc. Surg. 137, 1547-1549 (2009).
34. Comoglio C, Boffini M, El Qarra S et al. Aortic valve replacement and mitral valve repair as treatment of complications after percutaneous CoreValve implantation. J. Thorac. Cardiovasc. Surg. 138, 1025-1027 (2009).
35. Ong SH, Mueller R, Gerckens U. Iatrogenic dissection of the ascending aorta during TAVI sealed with the corevalve revalving prosthesis. Catheter Cardiovasc. Interv. 77(6), 910-914 (2011).
36. Abdel-Wahab M, Zahn R, Horack M et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 97(11), 899-906 (2011).
37. Gerckens U, Latsios G, Mueller R et al. Procedural and mid-term results in patients with aortic stenosis treated with implantation of 2 (in-series) CoreValve prostheses in 1 procedure. JACC Cardiovasc. Interv. 3(2), 244-250 (2010).
38. El-Khally Z, Thibault B, Staniloae C et al. Prognostic significance of newly acquired bundle branch block after aortic valve replacement. Am. J. Cardiol. 94, 1008-1011 (2004). (Pubitemid 39336432)
39. Limongelli G, Ducceschi V, D'Andrea A et al. Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience. Heart 89(8), 901-904 (2003). (Pubitemid 36920817)
40. Sinhal A, Altwegg L, Pasupati S et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc. Interv. 1(3), 305-309 (2008). (Pubitemid 351816793)
41. Piazza N, Onuma Y, Jesserun E et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc. Interv. 1, 310-316 (2008). (Pubitemid 351804194)
42. Khawaja MZ, Rajani R, Cook A et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative).Circulation 123(9), 951-960 (2011).
43. Kahlert P, Knipp SC, Schlamann M et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 121, 870-878 (2010).
44. Cribier A, Eltchaninoff H, Tron C et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J. Am. Coll. Cardiol. 47, 1214-1223 (2006).
45. Grube E, Buellesfeld L, Mueller R et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ. Cardiovasc. Interv. 1(3), 167-175 (2008).
46. Svensson LG, Dewey T, Kapadia S et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann. Thorac Surg. 86, 46-54 (2008).
47. Nietlispach F, Wijesinghe N, Gurvitch R et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc. Interv. 3(11), 1133-1138 (2010).
48. Piazza N, Schultz C, de Jaegere PP, Serruys PW. Implantation of two self-expanding aortic bioprosthetic valves during the same procedure? Insights into valve-in-valve implantation ('Russian doll concept').Catheter Cardiovasc. Interv. 73, 530-539 (2009).
49. Sinning J, Ghanem A, Steinhäuser H et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc. Interv. 3, 1141-1149 (2010).
50. Aregger F, Wenaweser P, Hellige GJ et al. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement Nephrol. Dial. Transplant. 24, 2175-2179 (2009).
51. Sherif MA, Abdel-Wahab M, Stöcker B et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the medtronic corevalve bioprosthesis. J. Am. Coll. Cardiol. 56, 1623-1629 (2010).
52. Détaint D, Lepage L, Himbert D et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve implantation impact of device and annulus discongruence. J. Am. Coll. Cardiol. Intv. 2, 821-827 (2009).